Fluidigm: Jonathan Day
Fluidigm has appointed Jonathan Day as VP of commercial operations, Americas. Day was most recently VP of sales and support, Americas, for Agena Bioscience. Previously, he held roles of increasing responsibility at Thermo Fisher Scientific. Day also previously worked for Affymetrix.
Thrive: David Daly
Thrive has appointed David Daly as CEO and to its board of directors. Prior to Thrive, Daly served as senior VP and general manager of commercial operations at Illumina. Before Illumina, Daly served as general manager and chief commercial officer at Foundation Medicine. Prior to Foundation Medicine, Daly led the oncology business unit at Life Technologies, served as CCO at Clarient, and held roles at Roche Diagnostics and Abbott Laboratories.
Pacific Biosciences: Stephen Turner
Pacific Biosciences Chief Technology Officer Stephen Turner has become a senior research fellow at nematode screening firm NemaMetrix of Eugene, Oregon. Turner, a cofounder of PacBio, holds a PhD in physics from Cornell University and will maintain his current position at the firm.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.